ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.82
0.00%
US Tech 100
20,286.80
0.37%
S&P 500
5,998.74
-0.38%
US Dollar vs CAD
1.39979
-0.07%
Bitcoin
97,320.39
1.74%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX
  6. Crescita Therapeutics Inc (CTX)

  7. Crescita Therapeutics Inc (CTX) News

CTX

Crescita Therapeutics (CTX)

Crescita Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:CTX
DateTimeSourceHeadlineSymbolCompany
06/01/20234:00AMPR Newswire (Canada)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
06/01/20234:00AMPR Newswire (US)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
06/01/20234:00AMPR Newswire (US)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
01/21/20216:30AMPR Newswire (US)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
01/21/20216:30AMPR Newswire (Canada)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
11/26/20206:30AMPR Newswire (Canada)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
11/26/20206:30AMPR Newswire (US)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
11/12/20206:30AMPR Newswire (Canada)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
11/12/20206:30AMPR Newswire (US)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
11/05/20206:30AMPR Newswire (Canada)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
11/05/20206:30AMPR Newswire (US)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
08/12/20206:30AMPR Newswire (US)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
08/12/20206:30AMPR Newswire (Canada)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
07/28/20206:30AMPR Newswire (US)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
07/28/20206:30AMPR Newswire (Canada)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
05/27/20206:30AMPR Newswire (US)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
05/27/20206:30AMPR Newswire (Canada)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
05/14/20207:30AMPR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
05/14/20207:30AMPR Newswire (Canada)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
04/28/20204:58PMPR Newswire (US)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
04/28/20204:58PMPR Newswire (Canada)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
03/24/20206:23PMPR Newswire (US)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
03/24/20206:23PMPR Newswire (Canada)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
03/18/20206:30AMPR Newswire (US)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
03/18/20206:30AMPR Newswire (Canada)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
03/10/20208:30AMPR Newswire (Canada)Pliaglis® finally available in CanadaTSX:CTXCrescita Therapeutics Inc
03/10/20208:30AMPR Newswire (Canada)Pliaglis® enfin disponible au CanadaTSX:CTXCrescita Therapeutics Inc
02/11/20206:30AMPR Newswire (US)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
02/11/20206:30AMPR Newswire (Canada)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
01/24/20206:30AMPR Newswire (US)Crescita Awarded Cannabis Research License from Health CanadaTSX:CTXCrescita Therapeutics Inc
 Showing the most relevant articles for your search:TSX:CTX

Your Recent History

NYSE
IONQ
IonQ
NASDAQ
COOP
Mr Cooper
USOTC
NBRI
North Bay Resources (PK)
COIN
XRPUSD
Ripple
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
NASDAQ
AMRN
Amarin
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
BIEL
Bioelectronics (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
LWLG
Lightwave Logic
USOTC
AFFU
Affluence (PK)
USOTC
RDAR
Raadr (PK)
USOTC
SPZI
Spooz (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49